A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

CRISPR Therapeutics’ CRSP Casgevy, a one-shot gene therapy, was approved in late 2023 and early 2024 across the United States and Europe for two blood disorder indications — sickle cell disease (SCD) ...

CRISPR offers the power to rewrite life’s code, promising cures for deadly diseases—but also the potential for devastating misuse when combined with AI.

A large language model can design and troubleshoot CRISPR protocols from scratch, allowing first-time researchers to achieve ...

Mars partners with Pairwise to use CRISPR tech for developing disease- and climate-resilient cacao, aiming to secure future ...

CRISPR, researchers identified Laccase2 as essential for hardening and darkening overwintering eggs in pea aphids. Knockout ...

The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute ...

Biotechnology outfit CRISPR Therapeutics (NASDAQ: CRSP) isn't a name on many investors' radar -- and understandably so. Its market capitalization is a mere $6 billion. The company ...

CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...

The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide.

CRISPR reached a big milestone this year by treating a disease inside the body—here's what's next for the technology. By Rebecca Sohn Updated Jul 28, 2021 5:01 PM EDT Get the Popular Science ...